ABT

Abbott (ABT) reachead $127.21 at the closing of the latest trading day, reflecting a +0.69% change compared to its last...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative biotech...

ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology and Consumer Diagnostics.

In the latest trading session, Abbott (ABT) closed at $113.04, marking a -0.69% move from the previous day.

Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Squawk on the Street' to discuss outlooks on the healthcare...

Here is how Abbott (ABT) and Acurx Pharmaceuticals, Inc. (ACXP) have performed compared to their sector so far this year.

ABBOTT PARK, Ill., Jan. 2, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2024 financial results on Wednesday,...

Want some solid dividend growth stocks with incredible track records of increasing their payouts? Here's a list of stocks that...

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock...